Absence of 5-HT(1B) Receptors is Associated with Impaired Impulse Control in Male 5-HT(1B) Knockout Mice
Overview
Affiliations
Background: Serotonin (5-HT) plays a complex regulatory role in processes like anxiety, depression, aggression, and impulse control. Due to the large amount of serotonergic receptors, knockout mice offer an important opportunity to investigate the role of specific receptors. The 5-HT(1B) receptor is thought to mediate aggression and impulse control. This was studied here in mice lacking 5-HT(1B) receptors (5-HT(1B) KO).
Methods: Wild type and 5-HT(1B) KO mice were exposed to several types of entrained and nonentrained stimuli. With telemetry, body temperature, heart rate, and locomotor activity were measured continuously during the different experiments.
Results: To nonentrained stimuli like disturbance stress and confrontation with an intruder, 5-HT(1B) KO mice showed exaggerated physiologic and behavioral responses. These mice displayed behavioral disinhibition, measured as increased social interest and aggression to an intruder mouse. However, in response to well-entrained stimuli like daily light transitions, responses were smaller in 5-HT(1B) KO than in wild type mice, suggesting that hyperreactivity is stimulus specific.
Conclusions: Serotonin 1B receptors are essential in impulse control by inhibiting responses to nonentrained stimuli. Therefore, the 5-HT(1B) KO mouse might be an important additional model for studying aspects of disinhibition in aggression and impulse control.
The nucleus accumbens in reward and aversion processing: insights and implications.
Xu Y, Lin Y, Yu M, Zhou K Front Behav Neurosci. 2024; 18:1420028.
PMID: 39184934 PMC: 11341389. DOI: 10.3389/fnbeh.2024.1420028.
Attention-deficit/hyperactive disorder updates.
Kessi M, Duan H, Xiong J, Chen B, He F, Yang L Front Mol Neurosci. 2022; 15:925049.
PMID: 36211978 PMC: 9532551. DOI: 10.3389/fnmol.2022.925049.
A role for reward valuation in the serotonergic modulation of impulsivity.
Desrochers S, Lesko E, Magalong V, Balsam P, Nautiyal K Psychopharmacology (Berl). 2021; 238(11):3293-3309.
PMID: 34390360 PMC: 8605981. DOI: 10.1007/s00213-021-05944-2.
Thompson Gray A, Simonetti J, Adegboye F, Jones C, Zurawski Z, Hamm H Eur J Neurosci. 2020; 52(1):2815-2826.
PMID: 32449556 PMC: 7520068. DOI: 10.1111/ejn.14836.
Kumstel S, Vasudevan P, Palme R, Zhang X, Wendt E, David R J Adv Res. 2019; 21:35-47.
PMID: 31641536 PMC: 6796693. DOI: 10.1016/j.jare.2019.09.002.